TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
NVO

Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

41.60$ +2.4% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Novo Nordisk A/S (NVO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 94.6% of the shares are freely tradable; institutional investors hold 10.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 10.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.00%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 94.6%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 3,334Mio.

Largest Shareholders

Institutions

Institutions NVO
Name Stake (%) Shares Change (%) Date
Dodge & Cox 0.46 20,397,110 +5.5 06/30/2026
Loomis, Sayles & Company LP 0.42 18,594,352 +9.3 06/30/2026
Franklin Templeton Inc 0.30 13,041,109 -18.9 06/30/2026
T. Rowe Price Associates, Inc. 0.27 11,704,719 +5.8 06/30/2026
Morgan Stanley - Brokerage Accounts 0.26 11,659,869 +7.3 06/30/2026
Bank of America Corp 0.25 11,176,712 +3.8 06/30/2026
Capital Research & Mgmt Co - Division 3 0.22 9,721,180 -17.6 06/30/2026
Folketrygdfondet 0.22 9,522,383 +4.9 06/30/2026
The Goldman Sachs Group Inc 0.21 9,180,490 +79.3 06/30/2026

Funds

Funds NVO
Name Stake (%) Shares Change (%) Date
Dodge & Cox Stock I 0.35 15,240,800 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?